FibroBiologics raises ~$4M in registered direct offering paid in gold coins; redeems $3.4M note

FibroBiologics, Inc.

Priced 3,540,000 shares and 8,570,203 pre-funded warrants at $0.3303/unit, gross proceeds ~$4M.
Payment in sovereign-issued .9999 fine gold coins valued at $4,069.18/oz, intent to liquidate to USD.
Concurrent private placement of 12,110,203 warrants at $0.3303, exercisable after stockholder approval.
Redeemed final Promissory Note (third tranche) of $3.4M principal plus 6% premium for total $3.604M.
Net proceeds for general corporate purposes, including debt satisfaction; offering closes Nov. 19, 2025.

item 1.01item 3.02item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.